國立虎尾科技大學 |

Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions/ by Sheikh Rayees, Inshah Din.
Author:	Rayees, Sheikh.
other author:	Din, Inshah.
Description:	IX, 69 p. 4 illus., 3 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cardiovascular Biology. -
Online resource:	https://doi.org/10.1007/978-3-030-70270-0
ISBN:	9783030702700

Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions
Rayees, Sheikh.

Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions[electronic resource] /by Sheikh Rayees, Inshah Din. - 1st ed. 2021. - IX, 69 p. 4 illus., 3 illus. in color.online resource. - SpringerBriefs in Immunology,2194-2781. - SpringerBriefs in Immunology,.

Asthma -- Pathophysiology asthma -- Airway inflammation and airway hyperresponsiveness -- Effects of inflammation -- Inflammatory cells involved in asthma -- Transcription factors involved in Th2 cell differentiation -- Current asthma treatments -- Cytokine-based therapies -- Transcription factor modulators -- Preclinical mouse models of asthma used to evaluate drug efficacy and properties and associated drawbacks -- Herbal treatments of asthma -- Traditional plants with anti-asthmatic potential -- Asthma Chinese Herbal Remedies -- Future potential of herbal-based medicinal treatment for management of asthma.

Asthma is a chronic airway disease affecting over 300 million people worldwide with an expected increase of an additional 100 million by 2025. Past decade has observed a notable increase in asthma prevalence on both national and global levels with highest rates observed in western countries (about 30%). Over the past 40 years, a drastic increase in global prevalence, morbidity, mortality, and economic burden have been observed due to asthma especially in children. The rising numbers of hospital admissions for asthma, especially young children, reflect an increase in severe asthma, poverty and lack of proper disease management. Worldwide, approximately 180,000 deaths annually are caused due to this condition. The financial burden on a single asthma patient per year in different western countries ranges from US$300–1,300. Asthma is an intricate respiratory disorder with differences in its severity, natural history and hence treatment response. These differences in intensities of various presentations such as bronchial hyper-responsiveness, airway inflammation, mucus production, airflow obstruction make asthma a heterogeneous disease. The mainstay of current therapies for asthma includes inhaled corticosteroids, phosphodiesterase inhibitors, leukotriene modifiers and β2-adrenoceptor agonists. Some of the currently available drugs are efficient in one or more aspects. However the associated side effects or heterogeneity of the disease limit their usefulness and efficacy, thereby putting a demand on development of new drugs and therapies. On the other hand, asthma has also been treated/managed via herbal medications. These approaches have been described in Unani, Ayurvedic or Chinese system of medicine since antiquity. In fact, several anti-asthmatic drugs were developed from herbs commonly utilized in the non-Western system of medicine. This book focuses on the pathophysiology of asthma, its medication (both herbal and modern), limitations and their future prospects.

ISBN: 9783030702700

Standard No.: 10.1007/978-3-030-70270-0doiSubjects--Topical Terms:

1209053
Cardiovascular Biology.

LC Class. No.: RC705-779

Dewey Class. No.: 616.2

Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions
LDR:04011nam a22003975i 4500 001 1048768
003 DE-He213
005 20211110072308.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030702700 $9 978-3-030-70270-0
024 7 $a 10.1007/978-3-030-70270-0 $2 doi
035 $a 978-3-030-70270-0
050 4 $a RC705-779
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
072 7 $a MJL $2 thema
082 0 4 $a 616.2 $2 23
100 1 $a Rayees, Sheikh. $e editor. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1323152
245 1 0 $a Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions $h [electronic resource] / $c by Sheikh Rayees, Inshah Din.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a IX, 69 p. 4 illus., 3 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a SpringerBriefs in Immunology, $x 2194-2781
505 0 $a Asthma -- Pathophysiology asthma -- Airway inflammation and airway hyperresponsiveness -- Effects of inflammation -- Inflammatory cells involved in asthma -- Transcription factors involved in Th2 cell differentiation -- Current asthma treatments -- Cytokine-based therapies -- Transcription factor modulators -- Preclinical mouse models of asthma used to evaluate drug efficacy and properties and associated drawbacks -- Herbal treatments of asthma -- Traditional plants with anti-asthmatic potential -- Asthma Chinese Herbal Remedies -- Future potential of herbal-based medicinal treatment for management of asthma.
520 $a Asthma is a chronic airway disease affecting over 300 million people worldwide with an expected increase of an additional 100 million by 2025. Past decade has observed a notable increase in asthma prevalence on both national and global levels with highest rates observed in western countries (about 30%). Over the past 40 years, a drastic increase in global prevalence, morbidity, mortality, and economic burden have been observed due to asthma especially in children. The rising numbers of hospital admissions for asthma, especially young children, reflect an increase in severe asthma, poverty and lack of proper disease management. Worldwide, approximately 180,000 deaths annually are caused due to this condition. The financial burden on a single asthma patient per year in different western countries ranges from US$300–1,300. Asthma is an intricate respiratory disorder with differences in its severity, natural history and hence treatment response. These differences in intensities of various presentations such as bronchial hyper-responsiveness, airway inflammation, mucus production, airflow obstruction make asthma a heterogeneous disease. The mainstay of current therapies for asthma includes inhaled corticosteroids, phosphodiesterase inhibitors, leukotriene modifiers and β2-adrenoceptor agonists. Some of the currently available drugs are efficient in one or more aspects. However the associated side effects or heterogeneity of the disease limit their usefulness and efficacy, thereby putting a demand on development of new drugs and therapies. On the other hand, asthma has also been treated/managed via herbal medications. These approaches have been described in Unani, Ayurvedic or Chinese system of medicine since antiquity. In fact, several anti-asthmatic drugs were developed from herbs commonly utilized in the non-Western system of medicine. This book focuses on the pathophysiology of asthma, its medication (both herbal and modern), limitations and their future prospects.
650 2 4 $a Cardiovascular Biology. $3 1209053
650 2 4 $a Complementary & Alternative Medicine. $3 679169
650 2 4 $a Plant Biochemistry. $3 668758
650 1 4 $a Pneumology/Respiratory System. $3 668561
650 0 $a Immunology. $3 592892
650 0 $a Cardiovascular system. $3 674313
650 0 $a Physiology. $3 673386
650 0 $a Complementary medicine. $3 1255001
650 0 $a Plant biochemistry. $3 1253547
650 0 $a Respiratory organs—Diseases. $3 1254083
700 1 $a Din, Inshah. $e editor. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1323153
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030702694
776 0 8 $i Printed edition: $z 9783030702717
830 0 $a SpringerBriefs in Immunology, $x 2194-2773 $3 1262382
856 4 0 $u https://doi.org/10.1007/978-3-030-70270-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)